Weight+6
OtherFor the Tochen formula in Group 1, ETT depth will be calculated by taking the infant's actual weight within the last 24 h and adding 6 cm.
NCT Number: NCT03591835
Endotracheal intubation is a frequent procedure performed in neonates with respiratory distress. Clinicians use different methods to estimate the intubation insertion depth.
In this study, the investigators aimed to compare the two different methods (kilogram + 6 cm and nasal septum-tragus length (NTL) + 1 cm) used to determine the endotracheal intubation insertion depth.
Looking for future studies?
Notify Me1 day–30 day
All sexes
Interventional
Not applicable
Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey (Türkiye)
Endotracheal intubation is a frequent procedure performed in neonates with respiratory distress. The ideal location of the tube is between the top of the 1st thoracic vertebra and the bottom of the 2nd thoracic vertebra in the X-ray. Clinicians use different methods to estimate the intubation insertion depth.
In this study, investigators aimed to compare the two different methods (kilogram+6 cm and nasal septum-tragus length (NTL)+ 1 cm) used to determine the endotracheal intubation insertion depth.
In this multicentre randomized prospective study, infants who had intubation indications in neonatal intensive care unit will be enrolled. The intubation tube will be fixed at the lip level using the Tochen formula (Group 1) or the NTL+1 cm formula (Group 2). The same brand endotracheal tubes will be used and after intubation the chest radiograph will be performed in the neutral position. Chest X-ray will be evaluated blindly by a single radiologist in the digital environment (above T1, in place and below T2).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
.
Exclusion criteria
For the Tochen formula in Group 1, ETT depth will be calculated by taking the infant's actual weight within the last 24 h and adding 6 cm.
The infants in Group 2 will be intubated by measuring the NTL, the distance from the basement of the nasal septum to the the tragus of the ear. Measurements will be recorded as centimeters.
Time frame: Up to 1 hour
After intubation a portable chest radiograph with digitalized measurements will be obtained to document ETT position. Head at the time of the radiograph will be stabilized in the neutral position. Chest X-ray will be evaluated blindly by a single radiologist in the digital environment (above upper border of T1, in place and below lower border of T2).
Time frame: Up to postmenstrual 52 weeks or till discharge
Pneumothorax by transillumination confirmed by chest x-ray.
Time frame: Postnatal age of 28 days or till discharge
BPD will be defined according to National Institutes of Health criteria.
Time frame: Up to postmenstrual 52 weeks or till discharge
We will record who died until discharge
Zekai Tahir Burak Women's Health Research and Education Hospital
Other
Is Nasal Septum-tragus Length Safe in Neonatal Endotracheal Intubation?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05451953
Neonatal Respiratory Failure, Tracheal Intubation Morbidity
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05036603
Atelectasis Neonatal, Bronchopulmonary Dysplasia
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT05508308
Female Urogenital Diseases and Pregnancy Complications, Neonatal Respiratory Distress Related Conditions
Lantoro, Abeokuta, Nigeria
View Trial DetailsNCT03154112
Cardiovascular Abnormalities, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial Details